Back to Journals » Drug Design, Development and Therapy » Volume 16

Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer [Corrigendum]

Authors Liu Y, Zhang N, Zhang H, Wang L, Duan Y, Wang X, Chen T, Liang Y , Li Y, Song X, Li C, Han D, Chen B, Zhao W, Yang Q

Received 21 December 2021

Accepted for publication 21 December 2021

Published 5 January 2022 Volume 2022:16 Pages 1—2


Liu Y, Zhang N, Zhang H, et al. Drug Des Devel Ther. 2020;14:3535–3545.

The authors have advised due to an error at the time of figure assembly, Figure 7C on page 3543 is incorrect. The correct Figure 7 is shown in Download Article.


The authors apologize for this error and advise it does not affect the results of the paper.

Read the original article

Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.